The Role of Resting Electrocardiogram in Screening for Primary Prevention of Cardiovascular Diseases in High-Risk Groups

  • Thong Nguyen
  • George Waits
  • Elsayed Z. Soliman
Novel and Emerging Risk Factors (K. Nasir, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Novel and Emerging Risk Factors


Purpose of Review

We sought to determine whether a role existed for the screening of certain populations with electrocardiogram (ECG) to improve risk stratification and facilitate risk reduction for primary prevention.

Recent Findings

Current screening guidelines do not recommend ECG screening for the general population.


While current guidelines, based on the available evidence, do not recommend ECG screening for the general population, in this report, we show that certain groups such as the elderly, those with hypertension, diabetes, or chronic kidney disease, may benefit from screening as a cost-effective means for identifying those at risk for future cardiovascular disease events. However, future studies are needed to standardize ECG markers and further qualify the screening value in these populations.


Resting ECG Cardiac screening Primary prevention 


Compliance with Ethical Standards

Conflict of Interest

Thong Nguyen, George Waits, and Elsayed Z. Soliman declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    WHO EMRO | Health promotion and disease prevention through population-based interventions, including action to address social determinants and health inequity | Public health functions | About WHO. Accessed December 8, 2017.
  2. 2.
    Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US preventive services task force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21–35. Accessed December 9, 2017.CrossRefPubMedGoogle Scholar
  3. 3.
    Seballos RJ. Principles of Screening. Published 2010. Accessed December 9, 2017.
  4. 4.
    Chou R, Qaseem A, Biebelhausen J, et al. Cardiac screening with electrocardiography, stress echocardiography, or myocardial perfusion imaging: advice for high-value care from the american college of physicians. Ann Intern Med. 2015;162(6):438–47. Scholar
  5. 5.
    Chou R, Arora B, Dana T, Fu R, Walker M, Humphrey L. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. preventive services task force. Ann Intern Med. 2011;155(6):375–85. Scholar
  6. 6.
    •• Shah AJ, Vaccarino V, Janssens ACJW, et al. An electrocardiogram-based risk equation for incident cardiovascular disease from the National Health and nutrition examination survey. JAMA Cardiol. 2016;1(7):779. A well-developed ECG risk equation based on various ECG parameters and patient demographics. CrossRefPubMedGoogle Scholar
  7. 7.
    Cuspidi C, Rescaldani M, Sala C, Negri F, Grassi G, Mancia G. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension. J Hypertens. 2012;30(11):2066–73. Scholar
  8. 8.
    Denes P, Larson JC, Lloyd-Jones DM, Prineas RJ. Greenland P. major And minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA. 2007;297(9):978–85. Scholar
  9. 9.
    Tervahauta M, Pekkanen J, Punsar S, Nissinen A. Resting electrocardiographic abnormalities as predictors of coronary events and Total mortality among elderly men. Am J Med. 1996;100:641–5. Accessed November 16, 2017.CrossRefPubMedGoogle Scholar
  10. 10.
    Viskin S. Long QT syndromes and tornado de pointes. Lancet. 1999;354:1625–33. Scholar
  11. 11.
    • Bang CN, Devereux RB, Okin PM. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction – a LIFE review. J Electrocardiol. 2014;47:630–5. The LIFE study showed an association between ECG strain in patients with LVH and increased cardiovascular events in hypertensive patients. CrossRefPubMedGoogle Scholar
  12. 12.
    Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham heart study and the epidemiology of cardiovascular diseases: a historical perspective. Lancet. 2014;383(9921):999–1008. Scholar
  13. 13.
    Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J. 2007;28(4):478–83. Scholar
  14. 14.
    Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47. Scholar
  15. 15.
    Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83(1):356–62. Scholar
  16. 16.
    • Deo R, Shou H, Soliman EZ, Yang W, Arkin JM, Zhang X, et al. Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD. J Am Soc Nephrol. 2016;27(2):559–69. CKD patients with increased ECG intervals (PR, QRS, QTc) correlate with adverse cardiovascular events. CrossRefPubMedGoogle Scholar
  17. 17.
    • Drawz PE, Babineau DC, Brecklin C, He J, Kallem RR, Soliman EZ, et al. Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC study. Am J Nephrol. 2013;38(6):517–28. Type 1 diabetics are linked to increased cardiovascular outcomes. CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Soliman EZ, Backlund J-YC, Bebu I, Orchard TJ, Zinman B, Lachin JM, et al. Electrocardiographic abnormalities and cardiovascular disease risk in type 1 diabetes: the epidemiology of diabetes interventions and complications (EDIC) study. Diabetes Care. 2017;40(6):793–9. Scholar
  19. 19.
    Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, Angermann C, et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol. 2009;4(2):394–400. Scholar
  20. 20.
    Cardoso CRL, Salles GF, Deccache W. QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke. 2003;34(9):2187–94. Scholar
  21. 21.
    • Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, et al. Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the diabetes heart study. Diabetes Care. 2014;37(5):1454–61. There is an association between prolonged QTc and all-cause mortality and CVD mortality in type 2 diabetics. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, et al. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33(7):1578–84. Scholar
  23. 23.
    Scheltens T, de Beus MF, Hoes AW, Rutten FH, Numans ME, Mosterd A, et al. The potential yield of ECG screening of hypertensive patients: the Utrecht health project. J Hypertens. 2010;28(7):1527–33. Scholar
  24. 24.
    Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, et al. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the losartan intervention for endpoint reduction in hypertension (LIFE) study. Circulation. 2006;113(1):67–73. Scholar
  25. 25.
    Satoshi J, Kenei S, Haruyuki T. Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients. Circ J. 2010;74:938–45.CrossRefGoogle Scholar
  26. 26.
    • Edison ES, Yano Y, Hoshide S, Kario K. Association of Electrocardiographic Left Ventricular Hypertrophy with Incident Cardiovascular Disease in Japanese older hypertensive patients. Am J Hypertens. 2015;28(4):527–34. Elderly population with hypertension and LVH are associated with a higher risk of cardiovascular events. CrossRefPubMedGoogle Scholar
  27. 27.
    • Fitzmaurice DA, Mccahon D, Baker J, et al. Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study. Fam Pract. 2014;31(3):298–302. This randomized cohort study found approximately 37% new cases of atrial fibrillation with a CHADS2 score of one or greater in the elderly population. CrossRefPubMedGoogle Scholar
  28. 28.
    • Almahmoud MF, O’Neal WT, Qureshi W, Soliman EZ. Electrocardiographic versus echocardiographic left ventricular hypertrophy in prediction of congestive heart failure in the elderly. Clin Cardiol. 2015;38(6):365–70. This population-based cohort study found that LVH was associated with increased rates of heart failure in the elderly population. CrossRefPubMedGoogle Scholar
  29. 29.
    • O’neal WT, Almahmoud MF, Qureshi W, Soliman EZ. Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly. J Stroke Cerebrovasc Dis. 2015;24(9):1991–7. This population-based cohort study found correlations between LVH and stroke. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Mureddu GF, Tarantini L, Agabiti N, Faggiano P, Masson S, Latini R, et al. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from “PREDICTOR”, a population based-study in central Italy. Eur J Heart Fail. 2013;15(10):1102–12. Scholar
  31. 31.
    Thomas Van Bemmel B, Vinkers DJ, Macfarlane PW, Gussekloo J, Westendorp RGJ. Markers of autonomic tone on a standard ECG are predictive of mortality in old age. Int J Cardiol. 2005;107:36–41. Scholar
  32. 32.
    Hodnesdal C, Prestgaard E, Erikssen G, Gjesdal K, Kjeldsen SE, Liestol K, et al. Rapidly upsloping ST-segment on exercise ECG: a marker of reduced coronary heart disease mortality risk. Eur J Prev Cardiol. 2013;20(4):541–8. Scholar
  33. 33.
    Moons KGM, Bots ML, Salonen JT, et al. Prediction of stroke in the general population in Europe (EUROSTROKE): is there a role for fibrinogen and electrocardiography? J Epidemiol Community Heal. 2002;56:30–6. Accessed December 12, 2017CrossRefGoogle Scholar
  34. 34.
    Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898–904. Scholar
  35. 35.
    Cushman WC, Grimm RH, Cutler JA, et al. Rationale and Design for the Blood Pressure Intervention of the action to control cardiovascular risk in diabetes (ACCORD) trial. Am J Cardiol. 2007;99(12):S44–55. Scholar
  36. 36.
    Rembold C. Number needed to screen: development of a statistic for disease screening. BMJ. 1998;317:307–11. Accessed January 14, 2018.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    EKGs and Exercise Stress Tests | Choosing Wisely. Accessed January 14, 2018.
  38. 38.
    Cohen D, Manuel DG, Tugwell P, Sanmartin C, Ramsay T. Direct healthcare costs of acute myocardial infarction in Canada’s elderly across the continuum of care. J Econ Ageing. 2014;3:44–9. Scholar
  39. 39.
    Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):1004–10. Scholar
  40. 40.
    • O’Neal WT, Mazur M, Bertoni AG, et al. Electrocardiographic predictors of heart failure with reduced versus preserved ejection fraction: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2017;6(6):e006023. Several ECG parameters are consistent with systolic heart failure and other ECG parameters are associated with diastolic heart failure. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Thong Nguyen
    • 1
  • George Waits
    • 1
  • Elsayed Z. Soliman
    • 2
  1. 1.Department of Internal MedicineWake Forest School of MedicineWinston-SalemUSA
  2. 2.Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and PreventionWake Forest School of MedicineWinston SalemUSA

Personalised recommendations